SLU-PP-332 5mg With/Without DMSO 60ml

Price range: $95.99 through $109.99

SLU-PP-332 – Potent ERRα Agonist for Metabolic & Performance Research

1 SLU-PP-332 5mg

1 DMSO Solution 60ml

SLU-PP-332 is a novel, selective Estrogen-Related Receptor Alpha (ERRα) agonist that directly enhances mitochondrial biogenesis and energy expenditure. Ideal for studying:

✔ Metabolic disease & obesity mechanisms
✔ Exercise endurance & muscle remodeling
✔ Neuroprotection & cognitive function
✔ Cellular energy & anti-aging pathways

Reconstitution Guidance: SLU-PP-332 is typically soluble in DMSO for creating a concentrated stock solution (e.g., 10-50 mM), which can then be further diluted in saline or cell culture media for final dosing. The final concentration of DMSO in any in vitro or in vivo application should not exceed 1% to avoid cytotoxicity.

Key Features:

≥98% HPLC/MS verified purity

Direct ERRα targeting for precise research

Lyophilized powder for optimal stability

Research use only (not for human/veterinary use)

HPLC Test Results: https://janoshik.com/tests/75909-SLUPP332_A3PF2VC6JB1F

Order now at EliteBiogenix.com for premium research compounds!

Disclaimer: This product is for laboratory research purposes only. Not for human or animal consumption.

selectWith DMSO, Without DMSO
SKU: N/A Category:
Description

SLU-PP-332 – Premium Research Compound for Metabolic & Endurance Studies (ERRα Agonist)

The SLU-PP-332 5mg With/Without DMSO 60mlERRα agonist research compound for metabolic studies is a potent and selective tool for investigating cellular energy and mitochondrial biogenesis. Because this novel small molecule directly activates the Estrogen-Related Receptor Alpha (ERRα), it functions as a master transcriptional regulator. Furthermore, researchers utilize this compound to explore pathways involving energy expenditure and adaptive thermogenesis in advanced laboratory models.

Mechanism of Action: Targeting the Master Metabolic Regulator

The profound effects of the SLU-PP-332 ERRα agonist research compound for metabolic studies are mediated through its highly specific interaction with nuclear receptors. By “switching on” ERRα, the compound triggers several critical downstream effects:

  • Transcriptional Activation: It binds to response elements to upregulate PGC-1α, the master regulator of mitochondrial creation.

  • Mitochondrial Biogenesis: The compound forces a robust increase in the density and oxidative capacity of existing mitochondria.

  • Substrate Utilization: It promotes a metabolic preference for fatty acids. Consequently, this helps researchers study glucose sparing and improved insulin sensitivity.

Key Research Applications

When scientists apply the SLU-PP-332 ERRα agonist research compound for metabolic studies, they observe striking results across various preclinical domains. Specifically, evidence-based studies highlight the following:

  1. Metabolic Disease & Obesity: Treatment in diet-induced obese models reveals marked improvements in glucose tolerance. Moreover, it promotes fat mass reduction without decreasing caloric intake.

  2. Exercise Performance: Rodents exhibit a staggering increase in running endurance, often exceeding 70% longer than control groups. This occurs because the compound transforms skeletal muscle into a fatigue-resistant phenotype.

  3. Neuroprotection: Since neurons are highly energy-dependent, SLU-PP-332 provides the necessary ATP to maintain synaptic function and resilience against oxidative stress.

Recommended Research Dosages & Protocols

To achieve consistent experimental results, you must follow established guidelines for the SLU-PP-332 ERRα agonist research compound for metabolic studies. The table below outlines standard laboratory protocols:

Research Model Suggested Dosage Administration Key Parameters
In Vitro 0.1 – 5.0 µM Dissolved in DMSO OCR, Gene Expression
Mouse Models 5 – 15 mg/kg IP Injection/Gavage Endurance, Glucose Tolerance
Rat Models 3 – 10 mg/kg IP Injection/Gavage Muscle Fiber Typing

Quality Assurance & Reconstitution

At EliteBiogenix, we provide high-purity SLU-PP-332 ERRα agonist research compound for metabolic studies ($\ge$98%) verified by HPLC. For proper handling, dissolve the lyophilized powder in DMSO to create a concentrated stock solution. Subsequently, you may dilute this in saline for final dosing. To maintain the highest stability, store the original vial at -20°C and protect it from light and moisture.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “SLU-PP-332 5mg With/Without DMSO 60ml”

Your email address will not be published. Required fields are marked *

Shipping & Delivery